Recent Findings from Shiraz University of Medical Sciences Provides New Insights into Mesenchymal Stem Cells (The Impact of Diabetic Glucose Concentration On Viability and Cardiac Differentiation of Mesenchymal Stem Cells).
In: Stem Cell Week, 2024-06-06, S. 537-537
serialPeriodical
Zugriff:
A recent study conducted by researchers at Shiraz University of Medical Sciences in Iran explored the impact of diabetic glucose concentration on the viability and cardiac differentiation of mesenchymal stem cells (MSCs). The study found that high glucose levels inhibited the normal proliferation and cardiac differentiation of MSCs. This finding is significant because diabetes is a common comorbidity in patients with cardiovascular diseases, and the glycemic status of these patients should be considered during stem cell transplantation. The study suggests that pretreatments or augmented cells may be necessary to maximize the benefits of stem cell therapy in these patients. [Extracted from the article]
Copyright of Stem Cell Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Recent Findings from Shiraz University of Medical Sciences Provides New Insights into Mesenchymal Stem Cells (The Impact of Diabetic Glucose Concentration On Viability and Cardiac Differentiation of Mesenchymal Stem Cells).
|
---|---|
Zeitschrift: | Stem Cell Week, 2024-06-06, S. 537-537 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
ISSN: | 1537-1360 (print) |
Sonstiges: |
|